The maintenance of muscle size and fiber composition requires contractile activity.
Introduction
The mass and functional capacity of skeletal muscle are tightly regulated by contractile activity, nutrient supply and hormones (1) . Contractile activity is necessary for postnatal muscle growth and for the maintenance of muscle mass in adults, and increased work can cause fiber hypertrophy (2) . Conversely, disuse or denervation causes rapid atrophy (3) .
Skeletal muscle also serves as the organisms major protein reservoir from which amino acids can be mobilized for gluconeogenesis, new protein synthesis or as an energy store (4) . Consequently, upon food deprivation and in many systemic disease states, including sepsis, cancer, burn injury, diabetes, cardiac and renal failure, there is a generalized muscle wasting, which results primarily from increased breakdown of muscle proteins, although protein synthesis also falls in most of these conditions (5) . In all these systemic catabolic states, the loss of muscle mass involves a common pattern of transcriptional changes, including induction of genes for protein degradation and decreased expression of various genes for growth-related and energy-yielding processes (5-7). We have termed this group of co-ordinately regulated genes, 'atrogenes'. Recent work indicates that the same transcriptional program occurs during atrophy induced by denervation and disuse as occurs in these catabolic states (8) .
In all these types of atrophying muscles, the ubiquitin-proteasome system is activated and catalyzes the degradation of the bulk of muscle proteins, especially myofibrillar components (5) . In addition, there is a dramatic fold) induction of two musclespecific ubiquitin ligases, atrogin-1/MAFbx and MuRF-1, whose induction occurs prior to the onset of muscle weight loss (7, 9) and is necessary for rapid atrophy (10) . On the other hand, the expression of these ubiquitin ligases and the enhancement of overall protein breakdown are blocked by the IGF-1/insulin/PI3K/AKT signaling pathway (11, 12) , which also activates protein synthesis and net growth of these muscles. The key mediators of this catabolic response during atrophy are the FoxO family of transcription factors, whose activity is suppressed during growth by phosphorylation by AKT (12, 13) , but whose expression and dephosphorylation rises in these catabolic states (7, 13) .
Activation of FoxO3 promotes the expression of atrogin-1 and other atrogenes, leading to a dramatic loss of muscle mass (13) . On the other hand, when FoxO3 function is blocked, atrogin-1 expression and the muscle atrophy induced by fasting or glucocorticoids are prevented (13) .
The mechanisms by which contractile activity preserves muscle mass, even in the face of catabolic signals (14-17), has long been a mystery. Muscle wasting does not occur similarly in all types of muscle fibers. Upon fasting (18) , exposure to glucocorticoids (19, 20) , sepsis (21) , and cancer cachexia (22, 23) , type II glycolytic muscle fibers show greater atrophy than the type I oxidative fibers. On the other hand, upon unloading or denervation, the fatigue-resistant, slow-contracting, dark muscles show more pronounced atrophy than fast-contracting, glycolytic, pale ones (24) . These differences appear to be due to the greater activity of neurons innervating the dark muscles (19) . In fact, increased activity protects pale muscles from glucocorticoid-induced atrophy and disuse sensitizes dark muscles to this catabolic hormone (19, 25) .
The present studies were undertaken to clarify how exercise can retard muscle wasting, and why fiber types differ in their susceptibility to atrophy. One attractive possibility is that the effects of activity on muscle size are linked to the PGC-1 family of coactivators (26) (27) (28) which are the prime regulators of mitochondrial content and oxidative metabolism and are critical in the maintenance of glucose, lipid and energy homeostasis in muscle and other tissues. PGC-1α was first identified as a PPARγ-interacting protein (29) and subsequently two other family members, PGC-related coactivator (PRC) and PGC-1β were identified (reviewed in (26) ). In skeletal muscle, PGC-1α functions as a critical metabolic sensor of motor neuron-induced calcium signaling (30) (31) (32) . Its expression is induced by both short term and chronic exercise in rodents and humans (33, 34) .
Transgenic expression of PGC-1α in fast-twitch, glycolytic muscles promotes mitochondrial biogenesis and oxidative metabolism (35) , and importantly, transforms the type IIb muscle fibers into a more oxidative phenotype. PGC-1α therefore appears to be an important mediator of exercise and motor-nerve activity in skeletal muscle .
In this study, we demonstrate that PGC-1α is an important factor opposing the effects of FoxO on muscle mass. Elevated levels of PGC-1α through transgenic expression reduce muscle atrophy upon denervation or fasting and the atrophy-promoting effects of FoxO3 apparently by suppressing the associated changes in transcription of key atrogenes.
Moreover, we show that PGC-1α expression falls dramatically after denervation and in various other types of muscle wasting, which enhance the FoxO-induced loss of muscle mass.
Results
To investigate whether a decrease in PGC-1α activity might be important in the transcriptional changes during muscle wasting, we initially examined how PGC-lα levels might vary in different experimentally-induced rat models of atrophy that mimic major human diseases (7) . The level of PGC-1α mRNA, as measured by real time PCR, fell dramatically in gastrocnemius muscles undergoing rapid atrophy caused by untreated streptozotocin-induced diabetes (36) , cancer cachexia induced with Yoshida ascites hepatoma (22) , and uremia induced by subtotal nephrectomy (37) (Fig 1a) . At the times studied, muscle protein degradation is markedly accelerated in all these conditions. Similarly, the loss of neural activity following section of the sciatic nerve also caused a sharp fall in PGC-1α expression (Fig 1b) . This marked reduction in PGC-1α mRNA occurred early, within the first day after operation and was maximal at 3 days (data not shown). In related studies in rat, we observed a similar rapid fall in PGC-1α mRNA after denervation or pure disuse of the gastrocnemius muscle induced by spinal isolation (8) .
Thus, its fall preceded the large decrease in muscle mass and persisted for at least two weeks (Fig 1b) (8) , after which time atrophy continues at a slower rate (8) .
Transgenic expression of PGC-1α protects muscles against atrophy. This rapid suppression of PGC-1α expression in many types of atrophy suggests that the decrease in this coactivator might contribute to the loss of muscle mass. To determine if PGC-1α affects atrophy, we used our strain of transgenic mice with muscle-specific PGC-1α expression (35) under the control of muscle creatine kinase (MCK) promoter. The MCK promoter is particularly active in glycolytic, type IIb muscle fibers (e.g. the tibialis anterior). Thus, in the transgenic animals, the level of PGC-1α expression in these fibers resembles the high level typically seen in the soleus, which contains primarily oxidative type IIa and type I fibers. Fibers from these transgenic animals have a more oxidative phenotype, as shown by greater content of succinic dehydrogenase and a shift from type IIb to type IIa and I fibers (Fig 2b, (35) ). Section of the sciatic nerve was performed in the transgenic and control mice. By twelve days, the denervated tibialis anterior in wild type animals showed more than a 40% reduction in mean fiber diameter. This decrease was mainly evident in large glycolytic type IIb fibers (Fig 2a,c) . By contrast, in the transgenic animals, although the fibers were generally smaller, denervation of the tibialis anterior caused much less atrophy. Only a 10% decrease in cross sectional area and a minor shift in fiber size distribution were seen (Fig 2b,c) .
To determine whether PGC-1α can also protect against other types of muscle wasting, we studied the susceptibility of muscles from these transgenic mice to fasting-induced atrophy, which is signaled by a fall in insulin and by glucocorticoids (38, 39) rather than by inactivity. By 48h after food was removed from the cages, the tibialis muscles from wild type animals showed a 25% reduction in mean fiber size, in accord with prior findings (40) . However, the muscles of mice PGC-1α transgenic mice were relatively resistant to atrophy, losing only 10% of their cross sectional area (Fig 2d) . Together, these experiments indicate that elevated levels of PGC-1α protects muscles against various types of atrophy, including that induced by disuse of a specific muscle or by endocrine changes; thus, the fall in PGC-1α in the atrophying muscles (Fig 1) is probably a key factor contributing to the loss of muscle mass.
PGC-1α alters expression of key atrophy-specific genes. We have previously shown that various types of muscle atrophy occur through a common program of transcriptional changes (7, 8) . Because of PGC-1α's capacity to protect against atrophy, we investigated whether transgenic expression of PGC-1α blocked the induction or action of genes critical in the atrophy process. The expression of three atrogenes involved in protein breakdown, the ubiquitin ligases, MuRF1 and atrogin-1, and the lysosomal hydrolase, cathepsin L, are dramatically induced in atrophying muscles (7) . As shown by real-time PCR (Fig. 3a) , mRNAs for each were strongly induced after denervation in wild type control mice, as described previously (8) . However, the increases in mRNA for atrogin-1, MuRF1 and cathepsin-L upon denervation were blunted by 40% in muscles expressing PGC-1α transgenically. In addition, the contralateral innervated muscles of the transgenic animals showed lower expression of these three genes. Interestingly, the activity of the MCK promoter also appears to be modulated by denervation, since in the transgenic mice PGC-1α mRNA levels in the denervated muscles were lower than in the innervated control.
Similarly, when the expression of these key atrogenes was monitored during muscle wasting induced by fasting, the marked induction of atrogin-1 following food deprivation was much smaller in the transgenic animals, and no induction of MuRF-1 was evident at all (Fig 3b) . Since the induction of these genes appears essential for rapid atrophy (7, 10) , the ability of PGC-1α to reduce muscle atrophy likely occurs in part by suppressing the transcriptional program activated in these muscles. In addition to the content of the key ubiquitin ligases atrogin-1 and MuRF-1, the major lysosomal protease, cathepsin L, which also contributes to the loss of muscle protein ( (41) flavoprotein 2, and NADH dehydrogenase (ubiquinone) 1 Beta subcomplex 5 (7, 8) . In microarrays from skeletal muscles of mice lacking PGC-1α, we found that 53% (nine) of these atrogenes were also suppressed compared with wild type animals (data not shown).
We also measured the expression of these genes by real time PCR in the denervated and contralateral innervated PGC-1α transgenic animals (Fig. 3c) . In each case, the mice producing PGC-1α transgenically had higher levels of these mRNAs. Their expression fell following denervation, but still remained significantly higher than in controls.
Together, these findings strongly suggest that the suppression of PGC-1α expression may underlie many of the transcriptional changes found in atrophying muscle, especially the decreased transcription of genes for ATP production.
Interestingly, the expression of several genes that may promote protein synthesis at the translational level, e.g. initiation factor α2 (E1Fα2), the ribosomal protein S5, and both arginine and glutamine tRNA synthase, also decreased during denervation atrophy, but were increased in the PGC-1α transgenic mouse (Fig 3d) . Although overall rates of protein synthesis are not significantly altered after denervation (42) or by PGC-1α expression in cultured myotubes (data not shown), these observations are further evidence that the fall in PGC-1α production helps determine the pattern of transcriptional changes seen during atrophy.
PGC-1α reduces FoxO3-dependent transcription of atrogin-1 and muscle atrophy.
Since mRNAs for key atrogenes including atrogin-1 was suppressed in the PGC-1α-transgenic animals, we examined in greater depth the effect of PGC-1α on the transcription of the atrogin-1 gene. In fasting and various catabolic states, where there is decreased insulin/IGF-1 or insulin-resistance, the forkhead family of transcription factors, including FoxO3, become dephosphorylated, enter the nucleus, and activate transcription (12, 13, 43) . FoxO3 activation alone is sufficient to cause dramatic muscle wasting in vivo (13) . To investigate whether PGC-1α might affect FoxO3-dependent transcription, we analysed the effect of PGC-1α on the atrogin-1 promoter in adult mouse muscles.
Tibialis anterior muscle fibers were electroporated with an atrogin-1 promoter-reporter construct (13) with or without constructs expressing PGC-1α and a constitutively active form of FoxO3, c.a.FoxO3A. This mutant FoxO3 cannot be phosphorylated /inactivated by AKT, because it carries mutations in the three AKT phosphorylation sites (T32A, S253A, and S315A). As shown in Fig 4a and reported previously (13 binding sites (Fig. 4a) . The ability of c.a.FoxO3 to bind to the atrogin-1 promoter was tested by chromatin immunoprecipitation (ChIP) assays in nuclei isolated from mouse skeletal muscle. As shown in Fig. 4b, c. a.FoxO3 electroporated into mouse muscle was found in complex with the atrogin-1 promoter. However PGC-1α strongly suppressed c.a.FoxO3 binding at this site (Fig.4b) .
As found in the reporter studies (Fig.4a ) and with ChIP (Fig.4b) , electroporation of PGC-1α together with c.a.FoxO3 caused a marked reduction in FoxO-dependent transcription.
Because of this ability to block the transcription by FoxO3, we analysed whether PGC-1α expression could also inhibit the rapid loss of muscle mass induced by FoxO3. Adult tibialis anterior muscles were electroporated with c.a.FoxO3 with or without PGC-1α.
The muscle fibers overexpressing c.a.FoxO3 underwent marked atrophy, losing more than 40% of their cross section area in eight days, in accord with prior findings (13) . In contrast, the coexpression of PGC-1α with FoxO3 blocked this response, and maintained fiber diameter close to that in the surrounding untransfected fibers (Fig. 4c) . These results together demonstrate that PGC-1α protects against muscle atrophy at least in part by suppressing FoxO-dependent transcription of critical atrophy-related genes.
Discussion
It is now clear that a specific program of transcriptional changes underlies the rapid atrophy of muscle seen in a wide variety of pathological states, ranging from denervation or disuse of a specific muscle, to fasting and systemic diseases (5, 7). Based upon the findings presented here, it is clear that the PGC-1α coactivator is an important determinant of this transcriptional program and the extent of fiber atrophy. First, the level of PGC-1α was shown to decrease sharply in muscles early during atrophy induced by section of the motor neuron in mice, as well as by diabetes, renal failure, and cancer cachexia in rats. This fall in PGC-1α expression with disuse is the mirror image of the increased expression after exercise (32-34), believed to be signaled by Ca 2+ influx and calcineurin (30, 31) . However, the mechanism for the surprising fall in PGC-1α in diverse catabolic states is unclear and represents an important question for study. In related studies, we have also observed similar changes in levels of the homologous coactivator PGC-1β ( (8), Z. Arany and B. Spiegelman, unpublished) which is not known to reflect contractile activity The systemic muscle wasting in these conditions appears to be triggered by insulin resistance and/or insulin-deficiency (44), glucocorticoids (45), and/or various monokines (46) . The marked reduction in PGC-1α mRNA in atrophying muscles occurs where FoxO factors are activated (13) and expressed at high rates (7). In related experiments, we observed a large fall in PGC-1α mRNA in rat muscle by one day after nerve section or complete inactivation with neurons intact (8) . In these different situations, the decrease in PGC-1α expression occurs early and precedes the rise in protein degradation and marked weight loss, and thus is sufficiently rapid to help signal the atrophy process. in muscle seem to be critical factors by which contractile activity determines muscle size as well as its enzymatic composition (Fig. 5) .
Methods

Animals and in vivo transfection experiments
PGC1a transgenic mice and singenic controls were starved for 48 hours, then muscles were collected and frozen in liquid nitrogen. Disuse atrophy was induced by cutting sciatic nerve of PGC1 transgenic and control mice. After 12 days mice were sacrified, muscles collected, serial sectioned and stained for SDH. In vivo transfection experiments were performed by intramuscular injection of plasmid DNA in tibialis anterior muscle followed by electroporation as described (13) . Muscles were removed at 8, 10, and 12 days after transfection and frozen in liquid nitrogen for subsequent analyses.
Gene expression analyses
Total RNA was isolated from skeletal muscle tissue using the Trizol reagent (Invitrogen).
For real-time PCR analysis, 1 µg of total RNA was reverse transcribed and the resulting cDNA used in semiquantitative PCR reactions with SYBR green dye on a 7300 real-time PCR system (ABI). Relative gene expression was calculated with the ΔΔCt method by normalization to 18S rRNA expression.
Immunohistochemistry and Fiber Size Measurements.
Mouse muscle fibers expressing HA-tagged or Flag-tagged proteins were stained in cryocross-sections fixed with 4% paraformaldehyde. Immunohistochemistry with anti-HA polyclonal antibody (Santa Cruz) anti-Flag polyclonal antibody (Sigma) was as previously described (13) . Muscle fiber size was measured in fibers transfected with the Foxo3 mutant with or whithout PGC-1α and in an equal number of untransfected fibers from the same muscle as described elsewhere (13) . All data are expressed as the mean ± SEM. Comparison were made by using the student's t test, with p < 0.05 being considered statistically significant
ChIP assay and promoter analysis. ChIP assay in adult skeletal muscles was performed 
